Skip to site alert.
Skip to content
Coronavirus information for patients and the CUIMC community.
Showing 21 - 30 of 100 results.
New SCAPE 2.0 system can serve as a critical tool to advance science and medicine
Trailblazer Gordana Vunjak-Novakovic, Ph.D., expertly manipulates a cell’s environment to change its behavior and function.
Gerard Karsenty is one of the scientists behind a decades-long exploration of the human fight-or-flight response.
Advances in stem cell biology and tissue engineering have led to the development of engineered tissue models or ‘organs-on-a-chip.’
Piero Dalerba, MD is one of the six inaugural Velocity fellows, whose innovative research projects to solve cancer are being funded by the money raised from the Velocity ride.
Genomic imprinting is an epigenetic mechanism that results in parent-of-origin monoallelic expression of specific genes, which precludes uniparental development and underlies various diseases.
Autism spectrum disorder (ASD) represents a major public health burden but translating promising treatment findings from preclinical non-human models of ASD to the clinic has remained challenging.
This study identifies a micro-RNA (miR-221) that, at the bottom of colonic crypts, is preferentially expressed in Lgr5+ cells as compared to Kit+ goblet cells.
Summer Research Program participant Kimberly Dempsey was mentored in the Emmanuelle Passegué lab by Amelie Collins, Assistant Professor of Pediatrics.
Maura Boldrini et al. find persistent adult neurogenesis in humans into the eighth decade of life, despite declines in quiescent stem cell pools, angiogenesis, and neuroplasticity.